Tag Archives: tuberous sclerosis

FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer

The US Food and Drug Administration (FDA) has approved everolimus (Afinitor) to treat patients with advanced pancreatic neuroendocrine tumors (pNETs).  pNETs is a rare, slow-growing form of pancreatic cancer.  In theUnited States, there are fewer than 1000 new pNET cases … Continue reading

Posted in Cancer, Pancreatic Cancer | Tagged , , , , , , , , , , , , , | Comments Off on FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer